Trial Profile
Comparative study for efficacy and tolerability of topical imiquimod 5% cream therapy versus photodynamic therapy (ALA-PDT) of actinic keratoses on the hands and forearms in organ transplant recipients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2018
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary) ; Aminolevulinic acid
- Indications Actinic keratosis
- Focus Therapeutic Use
- 03 Feb 2018 Status changed from recruiting to discontinued.
- 30 Oct 2014 New trial record